Baveno VI Variceal Screening Criteria: Clinical Guide

Overview

Identifies compensated advanced chronic liver disease patients who may avoid screening endoscopy using liver stiffness and platelet count.

Clinical Significance

Baveno VI criteria are met when liver stiffness is 150 ×10⁹/L; apply only in the intended population and with current guidance.

When to Use

• Use as structured clinical decision support when the required data are available and reliable.

How It Is Calculated

• The displayed variables are combined using the published equation, decision rule or weighted point system.

Interpretation

• Baveno VI criteria are met when liver stiffness is <20 kPa and platelets are >150 ×10⁹/L; apply only in the intended population and with current guidance.

Worked Example

Enter verified patient data in the displayed units; MedicalC applies the published model.

Limitations

• Risk and classification tools can be misapplied outside their validated population.
• Missing, estimated or non-contemporaneous data may materially change the result.

Clinical Pearls

• Document the input values, units, date and clinical setting with the result.
• Use serial scores only when the same instrument and measurement method are used consistently.

Common Mistakes

• Using the tool without confirming entry criteria.
• Using approximate or incorrectly converted laboratory values.
• Treating a prognostic score as a standalone treatment decision.

References

1. de Franchis R. J Hepatol. 2015;63:743-752. — Primary or supporting reference for the implemented model.